Dandavino R - Search Results

1

Initial bone loss in kidney transplant recipients: a prospective study.

Masse M, Girardin C, Ouimet D, Dandavino R, Boucher A, Madore F, Hébert MJ, Leblanc M, Pichette V. Masse M, et al. Among authors: dandavino r. Transplant Proc. 2001 Feb-Mar;33(1-2):1211. doi: 10.1016/s0041-1345(00)02390-3. Transplant Proc. 2001. PMID: 11267262 No abstract available.

2

The incidence, management, and evolution of rapamycin-related side effects in kidney transplant recipients.

Verhave J, Boucher A, Dandavino R, Collette S, Senécal L, Hebert MJ, Girardin C, Cardinal H. Verhave J, et al. Among authors: dandavino r. Clin Transplant. 2014 May;28(5):616-22. doi: 10.1111/ctr.12361. Epub 2014 Apr 19. Clin Transplant. 2014. PMID: 24654608

3

Standardization of a non-heart-beating model in the rat for studying the mechanisms of renal cell death associated with cardiac arrest and preservation of the kidney.

Bellemare S, Boucher A, Dandavino R, Marion A, Dubé P, Pichette V, Hébert M. Bellemare S, et al. Among authors: dandavino r. Transplant Proc. 2000 Mar;32(2):500-2. doi: 10.1016/s0041-1345(00)00824-1. Transplant Proc. 2000. PMID: 10715496 No abstract available.

4

CMV in kidney transplants in the tacrolimus-mycophenolate era.

Cailhier JF, Boucher A, Béliveau C, Poirier L, Delorme J, Weiss K, Laverdière M, Hébert MJ, Pichette V, Dandavino R. Cailhier JF, et al. Among authors: dandavino r. Transplant Proc. 2001 Feb-Mar;33(1-2):1196-7. doi: 10.1016/s0041-1345(00)02383-6. Transplant Proc. 2001. PMID: 11267255 No abstract available.

5

Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients.

Boucher A, Masse M, Lauzon L, Morin M, Dandavino R. Boucher A, et al. Among authors: dandavino r. Transplant Proc. 2002 Aug;34(5):1799-802. doi: 10.1016/s0041-1345(02)03083-x. Transplant Proc. 2002. PMID: 12176582 No abstract available.

6

Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.

Boucher A, Lord H, Collette S, Morin M, Dandavino R. Boucher A, et al. Among authors: dandavino r. Transplant Proc. 2006 Dec;38(10):3506-8. doi: 10.1016/j.transproceed.2006.10.127. Transplant Proc. 2006. PMID: 17175316

7

Conversion from calcineurin inhibitors to sirolimus in kidney transplant recipients: a retrospective cohort study.

Cardinal H, Froidure A, Dandavino R, Daloze P, Hébert MJ, Colette S, Boucher A. Cardinal H, et al. Among authors: dandavino r. Transplant Proc. 2009 Oct;41(8):3308-10. doi: 10.1016/j.transproceed.2009.08.049. Transplant Proc. 2009. PMID: 19857737

8

A pharmacoeconomic intrapatient comparison of Sandimmune capsules and Sandimmune oral solution in kidney transplant recipients.

Dandavino R, Boucher A, Gagne M, Labelle B. Dandavino R, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):985-6. Transplant Proc. 1991. PMID: 1989353 No abstract available.

9

Determinants of late allograft nephrectomy.

Madore F, Hébert MJ, Leblanc M, Girard R, Bastien E, Morin M, Beaudry C, Boucher A, Dandavino R. Madore F, et al. Among authors: dandavino r. Clin Nephrol. 1995 Nov;44(5):284-9. Clin Nephrol. 1995. PMID: 8605707

10

Risk-benefit of OKT3 prophylaxis in immunologic high-risk cadaver kidney transplant recipients.

Cogny-Van Weydevelt F, Prud'Homme L, Boucher A, Dandavino R. Cogny-Van Weydevelt F, et al. Among authors: dandavino r. Transplant Proc. 1997 Nov;29(7A):32S-34S. doi: 10.1016/s0041-1345(97)80009-7. Transplant Proc. 1997. PMID: 9366926 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters